Engineered T Cell Therapy for Gynecologic Malignancies: Challenges and Opportunities.
Xu Y, Jiang J, Wang Y, Wang W, Li H, Lai W, Zhou Z, Zhu W, Xiang Z, Wang Z, Zhu Z, Yu L, Huang X, Zheng H, Wu S.
Xu Y, et al.
Front Immunol. 2021 Jul 27;12:725330. doi: 10.3389/fimmu.2021.725330. eCollection 2021.
Front Immunol. 2021.
PMID: 34386017
Free PMC article.
Review.